New Developments in Mast Cell Biology: Clinical Implications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27316557.
- Also identified by DOI 10.1016/j.chest.2016.06.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mast cells (MCs) are present in connective tissue and at mucosal surfaces in all classes of vertebrates. In health, they contribute to tissue homeostasis, host defense, and tissue repair via multiple receptors regulating the release of a vast stockpile of proinflammatory mediators, proteases, and cytokines. However, these potentially protective cells are a double-edged sword. When there is a repeated or long-term stimulus, MC activation leads to tissue damage and dysfunction. Accordingly, MCs are implicated in the pathophysiologic aspects of numerous diseases covering all organs. Understanding the biology of MCs, their heterogeneity, mechanisms of activation, and signaling cascades may lead to the development of novel therapies for many diseases for which current treatments are lacking or are of poor efficacy. This review will focus on updates and developments in MC biology and their clinical implications, with a particular focus on their role in respiratory diseases.
Medical subject headings
- Asthma
- Cytokines
- Hypertension, Pulmonary
- Idiopathic Pulmonary Fibrosis
- Mast Cells
- Pneumonia
- Pulmonary Disease, Chronic Obstructive
- Smoking